Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Evaluation of Aspergillus-specific Lateral-Flow Device Test using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

J Clin Microbiol. 2019 Mar 6. pii: JCM.00095-19. doi: 10.1128/JCM.00095-19. [Epub ahead of print]

PMID:
30842231
2.

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata.

Shimamura S, Miyazaki T, Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Front Microbiol. 2019 Jan 25;10:27. doi: 10.3389/fmicb.2019.00027. eCollection 2019.

3.

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K, Sheppard DC.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.

PMID:
30684164
4.

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.

Minematsu A, Miyazaki T, Shimamura S, Nishikawa H, Nakayama H, Takazono T, Saijo T, Yamamoto K, Imamura Y, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2019 Jan 23;14(1):e0210883. doi: 10.1371/journal.pone.0210883. eCollection 2019.

5.

A case of bilateral emphysematous pyelonephritis caused by Candida albicans.

Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Mukae H.

J Infect Chemother. 2019 Apr;25(4):302-306. doi: 10.1016/j.jiac.2018.10.011. Epub 2018 Nov 15.

PMID:
30448360
6.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2018 Sep 28;12:321-322. doi: 10.2174/1874285801812010321. eCollection 2018. No abstract available.

7.

Enhanced angiotensinogen expression in neonates during kidney development.

Shono M, Urushihara M, Suga K, Watanabe N, Saijo T, Nakagawa R, Kagami S.

Clin Exp Nephrol. 2018 Oct 23. doi: 10.1007/s10157-018-1662-3. [Epub ahead of print]

PMID:
30353264
8.

[Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].

Ito T, Ishizumi T, Kataba H, Saijo T, Ikeda N.

Kyobu Geka. 2018 Aug;71(8):634-636. Japanese.

PMID:
30185764
9.

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.

Sakamoto H, Itonaga H, Sawayama Y, Taguchi J, Saijo T, Kuwatsuka S, Hashisako M, Kinoshita N, Oishi M, Doi H, Kosai K, Nishimoto K, Tanaka K, Yanagihara K, Mukae H, Izumikawa K, Miyazaki Y.

Intern Med. 2018;57(17):2567-2571. doi: 10.2169/internalmedicine.0474-17. Epub 2018 Sep 1.

10.

Examining Japanese women's preferences for a new style of postnatal care facility and its attributes.

Shen J, Nakashima T, Karasawa I, Furui T, Morishige K, Saijo T.

Int J Health Plann Manage. 2018 Oct;33(4):890-901. doi: 10.1002/hpm.2544. Epub 2018 May 21.

PMID:
29781211
11.

[The current situation and agendas in the prevention and control of non-communicable diseases in Vietnam].

Hattori K, Uda H, Hitomi Y, Yano R, Saijo T, Watanabe N, Satomi M, Yoshida A, Oishi O, Yamashita T, Kamenosono A.

Nihon Koshu Eisei Zasshi. 2018;65(4):170-178. doi: 10.11236/jph.65.4_170. Japanese.

12.

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02528-17. doi: 10.1128/AAC.02528-17. Print 2018 Jun.

13.

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

BMC Pulm Med. 2017 Dec 29;17(1):219. doi: 10.1186/s12890-017-0566-4.

14.

Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

Clin Infect Dis. 2017 Nov 13;65(11):1837-1842. doi: 10.1093/cid/cix695.

PMID:
29020161
15.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2017 May 31;11:92-97. doi: 10.2174/1874285801711010092. eCollection 2017.

16.

Examination of Dose Reduction Using Image Noise Reduction Technology in Cardiovascular X-ray Systems.

Saijo T, Seguchi S.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(6):451-459. doi: 10.6009/jjrt.2017_JSRT_73.6.451. Japanese.

17.

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.

Jayaram-Lindström N, Guterstam J, Häggkvist J, Ericson M, Malmlöf T, Schilström B, Halldin C, Cervenka S, Saijo T, Nordström AL, Franck J.

Transl Psychiatry. 2017 Apr 25;7(4):e1104. doi: 10.1038/tp.2017.79.

18.

Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients.

Oshima K, Takazono T, Saijo T, Tashiro M, Kurihara S, Yamamoto K, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

Med Mycol. 2018 Jan 1;56(1):88-94. doi: 10.1093/mmy/myx010.

PMID:
28419364
19.

A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.

Hirayama T, Takazono T, Iwata K, Senju H, Shimazaki T, Tashiro M, Saijo T, Tanaka T, Nakamura S, Imamura Y, Kojiro M, Miyazaki T, Tsukamoto M, Furumoto A, Morimoto K, Muraosa Y, Matsubara Y, Yanagihara K, Mukae H, Kamei K, Kohno S, Izumikawa K.

J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8.

PMID:
28395939
20.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.

Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

J Antimicrob Chemother. 2017 Jun 1;72(6):1709-1713. doi: 10.1093/jac/dkx020.

Supplemental Content

Loading ...
Support Center